{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:48:31Z","timestamp":1770518911702,"version":"3.49.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A girl diagnosed with neuroblastoma at 33 months underwent <jats:sup>123<\/jats:sup>I-MIBG scan after surgery and chemoradiotherapy. Although MIBG scan showed complete response, the bone marrow biopsy showed refractory disease. Therefore, she underwent <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT, which revealed bone marrow involvement and <jats:sup>68<\/jats:sup>Ga-DOTATATE\u2013avid brain metastasis. Rare physiological pineal gland uptake was also depicted. <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT showed active progressive disease earlier, before it was detectable with MIBG scan. For patients with MIBG-negative relapsed\/refractory disease, <jats:sup>68<\/jats:sup>Ga-DOTATATE may have an important role in restaging, detecting unsuspected metastasis, therapy planning.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002961","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T16:43:41Z","timestamp":1579884221000},"page":"326-329","source":"Crossref","is-referenced-by-count":27,"title":["The Complementary Role of 68Ga-DOTATATE PET\/CT in Neuroblastoma"],"prefix":"10.1097","volume":"45","author":[{"given":"Tu\u011f\u00e7e","family":"Telli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eser","family":"Lay Erg\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilge","family":"Volkan Salanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"\u00d6zgen Kiratli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/pbc.21932","article-title":"(123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: results from a prospective multicenter trial","volume":"52","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1200\/JCO.2008.20.5732","article-title":"Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma","volume":"27","year":"2009","journal-title":"J Clin Oncol"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00259-018-4070-8","article-title":"Guidelines on nuclear medicine imaging in neuroblastoma","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00259-005-1890-0","article-title":"Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow","volume":"32","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/mpo.2950210111","article-title":"Evaluation of bone marrow metastasis of neuroblastoma and changes after chemotherapy by MRI","volume":"21","year":"1993","journal-title":"Med Pediatr Oncol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2967\/jnumed.108.060467","article-title":"123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma","volume":"50","year":"2009","journal-title":"J Nucl Med"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cncr.30380","article-title":"Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the international Neuroblastoma response criteria bone marrow working group","volume":"123","year":"2017","journal-title":"Cancer"},{"key":"bib8-20230925","first-page":"1","article-title":"Characterization of somatostatin receptors on human neuroblastoma tumors","volume":"5","year":"1994","journal-title":"Cell Growth Differ"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MPH.0000000000000411","article-title":"Initial experience with gallium-68 DOTA-Octreotate PET\/CT and peptide receptor radionuclide therapy for Pediatric patients with refractory metastatic Neuroblastoma","volume":"38","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1874471011666171215093112","article-title":"Review: the role of radiolabeled DOTA-conjugated peptides for imaging and treatment of childhood neuroblastoma","volume":"11","year":"2018","journal-title":"Curr Radiopharm"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:02:54Z","timestamp":1695621774000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002961","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,3]]}}}